Cite

HARVARD Citation

    Tokaca, N. et al. (n.d.). 69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme. Lung cancer. pp. S32-S33. [Online]. 
  
Back to record